INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 131 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $20 | -31.0% | 24,035 | +26.2% | 0.00% | – |
| Q4 2022 | $29 | -99.9% | 19,048 | +13.9% | 0.00% | – |
| Q3 2022 | $28,000 | +7.7% | 16,726 | +8.2% | 0.00% | – |
| Q2 2022 | $26,000 | -50.9% | 15,453 | +9.4% | 0.00% | – |
| Q1 2022 | $53,000 | -18.5% | 14,121 | +9.0% | 0.00% | – |
| Q4 2021 | $65,000 | -23.5% | 12,957 | +9.6% | 0.00% | – |
| Q3 2021 | $85,000 | -22.7% | 11,824 | 0.0% | 0.00% | – |
| Q2 2021 | $110,000 | +0.9% | 11,824 | 0.0% | 0.00% | – |
| Q1 2021 | $109,000 | +28.2% | 11,824 | +23.5% | 0.00% | – |
| Q4 2020 | $85,000 | -23.4% | 9,575 | 0.0% | 0.00% | – |
| Q3 2020 | $111,000 | -56.6% | 9,575 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $256,000 | +556.4% | 9,575 | -28.4% | 0.00% | – |
| Q2 2019 | $39,000 | +77.3% | 13,380 | +130.3% | 0.00% | – |
| Q1 2019 | $22,000 | 0.0% | 5,810 | 0.0% | 0.00% | – |
| Q4 2018 | $22,000 | -31.2% | 5,810 | 0.0% | 0.00% | – |
| Q3 2018 | $32,000 | +39.1% | 5,810 | 0.0% | 0.00% | – |
| Q2 2018 | $23,000 | -14.8% | 5,810 | 0.0% | 0.00% | – |
| Q1 2018 | $27,000 | +12.5% | 5,810 | 0.0% | 0.00% | – |
| Q4 2017 | $24,000 | -35.1% | 5,810 | 0.0% | 0.00% | – |
| Q3 2017 | $37,000 | -17.8% | 5,810 | 0.0% | 0.00% | – |
| Q2 2017 | $45,000 | +18.4% | 5,810 | 0.0% | 0.00% | – |
| Q1 2017 | $38,000 | -5.0% | 5,810 | 0.0% | 0.00% | – |
| Q4 2016 | $40,000 | -63.0% | 5,810 | -50.0% | 0.00% | – |
| Q3 2016 | $108,000 | +103.8% | 11,620 | +100.0% | 0.00% | – |
| Q2 2016 | $53,000 | +6.0% | 5,810 | 0.0% | 0.00% | – |
| Q1 2016 | $50,000 | +28.2% | 5,810 | 0.0% | 0.00% | – |
| Q4 2015 | $39,000 | +14.7% | 5,810 | 0.0% | 0.00% | – |
| Q3 2015 | $34,000 | -29.2% | 5,810 | -2.3% | 0.00% | – |
| Q2 2015 | $48,000 | +4700.0% | 5,945 | +4303.7% | 0.00% | – |
| Q1 2015 | $1,000 | -93.3% | 135 | -91.8% | 0.00% | – |
| Q4 2014 | $15,000 | -40.0% | 1,654 | -31.2% | 0.00% | – |
| Q3 2014 | $25,000 | – | 2,404 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 200,000 | $998,000 | 0.36% |
| Green Alpha Advisors, LLC | 72,647 | $363,000 | 0.24% |
| Skaana Management L.P. | 227,851 | $1,137,000 | 0.18% |
| SEVEN EIGHT CAPITAL, LP | 196,351 | $980,000 | 0.18% |
| Defender Capital, LLC. | 103,038 | $514,000 | 0.16% |
| Skaana Management L.P. | 206,300 | $1,029,000 | 0.16% |
| WASATCH ADVISORS LP | 4,926,125 | $24,581,000 | 0.10% |
| Parametrica Management Ltd | 16,183 | $81,000 | 0.08% |
| Cedar Brook Financial Partners, LLC | 54,500 | $272,000 | 0.07% |
| Hennion & Walsh Asset Management, Inc. | 274,703 | $1,371,000 | 0.07% |